PATENT CLAIM ANALYSIS

Application Number: 16148825
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-03
Patent Classification: ["514", "651000"]

Abstract:
The present invention is directed to pharmaceutical compositions and methods of treating traumatic brain injury (TBI). The invention is also directed to pharmaceutical compositions and methods of treating a transient hypoxic and/or ischemic condition in the central nervous system. More specifically, the present invention is directed to pharmaceutical compositions and methods of reducing the occurrence of neuronal cell death in the central nervous system, such as, reducing the occurrence brain cell death in the hippocampus and/or the cortex.

Claim (Index 26):
The pharmaceutical composition of  claim 20  or  25 , wherein the TBI event is selected from the group consisting of whiplash, a blast wave impact, and blunt force trauma, and wherein the TBI event is of sufficient force to cause neuronal cell damage or death.

Metadata:
- Claim Count in Document: 107.0
- Percentile: 97.0
- Lexical Diversity: 2.0
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14911943', '14002429', '13175518', '13621977', '14426832']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8110729556437282
- 35 USC 102 Novelty (BERT): 0.5237776357036419
- Combined Prediction Score: 0.7823434236497195
- Mean Citation Score: 301.7414760000001
- Max Citation Score: 315.034
- Similarity Product: 182.08204997086528

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test